Caisse De Depot Et Placement Du Quebec Galapagos Nv Transaction History

Caisse De Depot Et Placement Du Quebec

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $3.82 Million - $5.5 Million	-29,300 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$111.45 - $128.93 $1.87 Million - $2.17 Million	16,800 Added 134.4%	29,300 $3.78 Million
Q2 2018 Aug 13, 2018	BUY	$88.4 - $105.34 $1.11 Million - $1.32 Million	12,500 New	12,500 $1.15 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.